Results 161 to 170 of about 84,218 (260)

Autosomal Dominant Erythrocytosis Caused by Non‐Renal Erythropoietin (EPO) Due to EPO c.‐136 G>A Germline Mutation

open access: yesAmerican Journal of Hematology, EarlyView.
A novel erythropoietin (EPO) promoter mutation (c.‐136 G>A) causes autosomal dominant erythrocytosis via non‐renal expression of EPO. ABSTRACT We previously reported a five‐generation kindred with autosomal dominant erythrocytosis associated with a novel germline promoter variant in the erythropoietin (EPO) gene (EPO c.‐136 G>A).
Lucie Lanikova   +10 more
wiley   +1 more source

Dentin Autograft as a Pulp Capping Material: A Systematic Review.

open access: yesJ Pharm Bioallied Sci
Chaudhari WA   +5 more
europepmc   +1 more source

Effect of hemostatic agents on the outcome of pulpotomy in primary and permanent teeth: A systematic review. [PDF]

open access: yesJ Oral Biol Craniofac Res
Kumar A   +5 more
europepmc   +1 more source

Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations

open access: yesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT In Attention Deficit Hyperactivity Disorder (ADHD), methylphenidate is one of the most widely used drugs, in which patient response significantly impacts prognosis. This study aimed to characterize the molecular profile of 10 genes associated with methylphenidate therapy.
Aline Pasquini Santos   +14 more
wiley   +1 more source

Application and mechanism study of EMD-Gel composite scaffold in dental pulp tissue repair. [PDF]

open access: yesFront Bioeng Biotechnol
Gui L   +6 more
europepmc   +1 more source

Mannose‐Modified Cationic Liposome‐Based mRNA Therapeutics for Improved Triple‐Negative Breast Cancer Immunotherapy

open access: yesAdvanced NanoBiomed Research, EarlyView.
Schematic illustration of mTEM8‐loaded cationic liposome (cLipo‐Man/mTEM8) therapeutics for improved triple‐negative breast cancer immunotherapy. Despite triple‐negative breast cancer (TNBC) is the most heterogeneous and aggressive subtype of breast cancer, immunotherapy is emerging as a promising therapy.
Kexin Deng   +10 more
wiley   +1 more source

Barcode-free hit discovery from massive libraries enabled by automated small molecule structure annotation. [PDF]

open access: yesNat Commun
van der Nol E   +14 more
europepmc   +1 more source

A High-throughput Screening of a Chemical Compound Library in Ovarian Cancer Stem Cells.

open access: yesCombinatorial chemistry & high throughput screening, 2018
Francesca Ricci   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy